Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Clover Health Investments...

    NASDAQ: CLOV · Real-Time Price · USD
    2.92
    0.04 (1.21%)
    At close: Jun 16, 2025, 3:59 PM
    2.92
    0.17%
    After-hours: Jun 16, 2025, 07:57 PM EDT

    Clover Health Investments Statistics

    Share Statistics

    Clover Health Investments has 508.92M shares outstanding. The number of shares has increased by 2.91% in one year.

    Shares Outstanding

    n/a
    		 508.92M

    Shares Change (YoY)

    n/a
    		 2.91%

    Shares Change (QoQ)

    n/a
    		 1.96%

    Owned by Institutions (%)

    n/a
    		 18.95%

    Shares Floating

    n/a
    		 466.84M

    Failed to Deliver (FTD) Shares

    n/a
    		 500

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 20.44M, so 4.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 20.44M

    Short % of Shares Out

    n/a
    		 4.02%

    Short % of Float

    n/a
    		 5.04%

    Short Ratio (days to cover)

    n/a
    		 3.28

    Valuation Ratios

    The PE ratio is -35.89 and the forward PE ratio is -144.25. Clover Health Investments's PEG ratio is 0.44.

    PE Ratio

    n/a
    		 -35.89

    Forward PE

    n/a
    		 -144.25

    PS Ratio

    n/a
    		 1.13

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 4.52

    P/FCF Ratio

    n/a
    		 46.37

    PEG Ratio

    n/a
    		 0.44
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Clover Health Investments.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.61

    Quick Ratio

    n/a
    		 1.61

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $2,405,492.98

    Profits Per Employee

    n/a
    		 $-75,454.39

    Employee Count

    n/a
    		 570

    Asset Turnover

    n/a
    		 2.36

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 153.91% in the last 52 weeks. The beta is 1.93, so Clover Health Investments's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.93

    52-Week Price Change

    n/a
    		 153.91%

    50-Day Moving Average

    n/a
    		 3.35

    200-Day Moving Average

    n/a
    		 3.56

    Relative Strength Index (RSI)

    n/a
    		 33.68

    Average Volume (20 Days)

    n/a
    		 5,691,809

    Income Statement

    In the last 12 months, Clover Health Investments had revenue of 1.37B and earned -43.01M in profits. Earnings per share was -0.08.

    Revenue

    n/a
    		 1.37B

    Gross Profit

    n/a
    		 364.8M

    Operating Income

    n/a
    		 -45.75M

    Net Income

    n/a
    		 -43.01M

    EBITDA

    n/a
    		 -44.94M

    EBIT

    n/a
    		 -46.27M

    Earnings Per Share (EPS)

    n/a
    		 -0.08
    Full Income Statement

    Balance Sheet

    The company has 194.54M in cash and 0 in debt, giving a net cash position of 194.54M.

    Cash & Cash Equivalents

    n/a
    		 194.54M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -2.2B

    Total Assets

    n/a
    		 583.72M

    Working Capital

    n/a
    		 115.76M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 34.84M and capital expenditures -1.56M, giving a free cash flow of 33.29M.

    Operating Cash Flow

    n/a
    		 34.84M

    Capital Expenditures

    n/a
    		 -1.56M

    Free Cash Flow

    n/a
    		 33.29M

    FCF Per Share

    n/a
    		 0.07
    Full Cash Flow Statement

    Margins

    Gross margin is 26.61%, with operating and profit margins of -3.34% and -3.14%.

    Gross Margin

    n/a
    		 26.61%

    Operating Margin

    n/a
    		 -3.34%

    Pretax Margin

    n/a
    		 -3.37%

    Profit Margin

    n/a
    		 -3.14%

    EBITDA Margin

    n/a
    		 -3.28%

    EBIT Margin

    n/a
    		 -3.34%

    FCF Margin

    n/a
    		 2.43%

    Dividends & Yields

    CLOV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLOV is $4.5, which is 54.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4.5

    Price Target Difference

    n/a
    		 54.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.22

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist